Article
The rVSV-EBOV vaccine provides limited cross-protection against Sudan virus in guinea pigs
2022-11-11
Abstract excerpt
Recombinant vesicular stomatitis viruses (rVSVs) engineered to express heterologous viral glycoproteins have proven to be remarkably effective vaccines. Indeed, rVSV-EBOV, which expresses the Ebola virus (EBOV) glycoprotein, recently received clinical approval in the United States and Europe for its ability to prevent EBOV disease. Analogous rVSV vaccines expressing the glycoproteins of different human-pathogenic...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 40b81b2f-8b01-5cc1-97b9-f7a63acaeafa
- DOI
- 10.1101/2022.11.11.516195
